TY - JOUR
T1 - Análisis bibliométrico de la producción científica Peruana sobre la COVID-19
AU - Vásquez-Uriarte, Karina
AU - Roque-Henriquez, Joel Christian
AU - Angulo-Bazán, Yolanda
AU - Ortiz, Juana Aurelia Ninatanta
N1 - Publisher Copyright:
© 2021, Instituto Nacional de Salud. All rights reserved.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Objective: To describe the Peruvian scientific output on COVID-19 up to January 31, 2021. Materials and methods: We carried out a bibliometric study using two databases (MEDLINE and SciELO). We included original or short original articles with at least one author with Peruvian institutional affiliation. Scientific output was described according to: institution, approval by a Research Ethics Committee, re-gistration in the platforms established by regulations, scientific journals in which they were published, research funding, and Peruvian collaboration networks. Results: A total of 106 articles were analyzed, only three (2.8%) were clinical trials. Of the top 10 institutions with the highest scientific output, only two did not belong to the education sector. A total of 53 (50.0%) articles had no information regarding ethical aspects or it was not explicitly stated whether or not it was approved by a Research Ethics Com-mittee. Only 8 (7.7%) of 104 articles were registered in PRISA; 12 (11.3%) articles were published in Peruvian journals. Regarding funding, 71 (67.0%) investigations did not specify the source or they were self-financed. We found international collaboration in 70 publications (66.0%). Conclusions: The most productive Peruvian institutions are found in Lima. Half of the articles did not state ethical aspects in any part of the document. Almost all of the studies were not registered on the platforms established by regulations. In more than half of the articles the source of funding is not stated or they were self-financed.
AB - Objective: To describe the Peruvian scientific output on COVID-19 up to January 31, 2021. Materials and methods: We carried out a bibliometric study using two databases (MEDLINE and SciELO). We included original or short original articles with at least one author with Peruvian institutional affiliation. Scientific output was described according to: institution, approval by a Research Ethics Committee, re-gistration in the platforms established by regulations, scientific journals in which they were published, research funding, and Peruvian collaboration networks. Results: A total of 106 articles were analyzed, only three (2.8%) were clinical trials. Of the top 10 institutions with the highest scientific output, only two did not belong to the education sector. A total of 53 (50.0%) articles had no information regarding ethical aspects or it was not explicitly stated whether or not it was approved by a Research Ethics Com-mittee. Only 8 (7.7%) of 104 articles were registered in PRISA; 12 (11.3%) articles were published in Peruvian journals. Regarding funding, 71 (67.0%) investigations did not specify the source or they were self-financed. We found international collaboration in 70 publications (66.0%). Conclusions: The most productive Peruvian institutions are found in Lima. Half of the articles did not state ethical aspects in any part of the document. Almost all of the studies were not registered on the platforms established by regulations. In more than half of the articles the source of funding is not stated or they were self-financed.
KW - Bibliometrics
KW - Collaboration indicator
KW - Coronavirus infections
KW - Ethics committees, research
KW - MEDLINE
KW - National scientific and technological production
KW - Pandemics
KW - Periodical
KW - Peru
KW - Scientific publication indi-cators
UR - http://www.scopus.com/inward/record.url?scp=85114034593&partnerID=8YFLogxK
U2 - 10.17843/rpmesp.2021.382.7470
DO - 10.17843/rpmesp.2021.382.7470
M3 - Artículo
C2 - 34468568
AN - SCOPUS:85114034593
SN - 1726-4634
VL - 38
SP - 224
EP - 231
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 2
ER -